In this issue of Dermatology Times, we’ve put together a snapshot-in-time update about the status of the COVID-19 outbreak to date, and what dermatologists can do to safeguard practices while still providing essential care. Additionally, we share new insights on tackling itch in atopic dermatitis, as well as new treatments for rosacea and acne.
 
Dermatology Times cover
COVID-19: Experts discuss virulence, potential treatments, controversies
Governments and the scientific community are racing to identify new and existing drugs that might help flatten the curve and save lives. Read from experts as they discuss the latest news and research surrounding possible treatments for COVID-19.

New ways to tackle itch in atopic dermatitis
Traditional and popular treatments aimed at calming the often intense pruritus that accompanies atopic dermatitis might not be optimal therapeutic options, according to a recent review.
COVID-19 pandemic requires vigilance, not panic
In combatting the pandemic, dermatologists must take critical steps to adapt operations while still providing essential patient care and preventing exposure in office settings, experts say.
An update on antibiotic use for acne
Read insights from James Q. Del Rosso, D.O., as he discusses antibiotic resistance, isotretinoin relapse, and laboratory monitoring for patients on isotretinoin and spironolactone.

Connect with us on Twitter and Facebook for daily updates.